Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging

Muscle and Nerve

Volumn 40, Issue 5, 2009, Pages 815-826

  Kobayashi, Masanori ^a,b   Nakamura, Akinori ^a   Hasegawa, Daisuke ^b   Fujita, Michio ^b   Orima, Hiromitsu ^b   Takeda, Shin'ichi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Chemical shift selective fat suppressed T2 weighted imaging; Duchenne muscular dystrophy; Dystrophic dog; Magnetic resonance imaging; Myopathy

Indexed keywords

DYSTROPHIN; GADOLINIUM PENTETATE;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; MOUSE; MUSCLE BIOPSY; MUSCLE NECROSIS; MYOSITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOLEMMA; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL;

EID: 71549145959     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21384     Document Type: Article

References (48)

1. Moser H. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 1984;66: 17-40. (Pubitemid 14159042)
2. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-517.
3. Campbell KP. Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell 1995;80:675-679.
4. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990;345:315-319.
5. Cullen MJ, Mastaglia FL. Morphological changes in dystrophic muscle. Br Med Bull 1980;36:145-152.
6. Marden FA, Connolly AM, Siegel MJ, Rubin DA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skel Radiol 2005;34:140-148.
7. Coulton GR, Morgan JE, Partridge TA, Sloper JC. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 1988;14:53-70.
8. Valentine BA, Cooper BJ, de Lahunta A, O'Quinn R, Blue JT. Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci 1988;88:69-81.
9. Muntoni F, Mateddu A, Marchei F, Clerk A, Serra G. Muscular weakness in the mdx mouse. J Neurol Sci 1993;120: 71-77.
10. Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl) 1986;69:91-95. (Pubitemid 16146255)
11. Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 1988;334:154-156.
12. Valentine BA, Cooper BJ, Cummings JF, de Lahunta A. Canine X-linked muscular dystrophy: morphologic lesions. J Neurol Sci 1990;97:1-23.
13. Shimatsu Y, Katagiri K, Furuta T, Nakura M, Tanioka Y, Yuasa K, et al. Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim 2003;52:93-97. (Pubitemid 41349972)
14. Shimatsu Y, Yoshimura M, Yuasa K, Urasawa N, Tomohiro M, Nakura M, et al. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. Acta Myol 2005;24:145-154. (Pubitemid 43287352)
15. Yugeta N, Urasawa N, Fujii Y, Yoshimura M, Yuasa K, Wada MR, et al. Cardiac involvement in beagle-based canine Xlinked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies. BMC Cardiovasc Disord 2006;6:47. (Pubitemid 44942874)
16. Liu M, Chino N, Ishihara T. Muscle damage progression in Duchenne muscular dystrophy evaluated by a new quantitative computed tomography method. Arch Phys Med Rehabil 1993;74:507-514. (Pubitemid 23141400)
17. Shimizu J, Matsumura K, Kawai M, Kunimoto M, Nakano I. X-ray CT of Duchenne muscular dystrophy skeletal muscles-chronological study for five years [in Japanese]. Rinsho Shinkeigaku 1991;31:953-959.
18. Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007;25: 433-440. (Pubitemid 46204590)
19. Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging 1994;4:59-64.
20. Schreiber A, Smith WL, Ionasescu V, Zellweger H, Franken EA, Dunn V, et al. Magnetic resonance imaging of children with Duchennemuscular dystrophy. Pediatr Radiol 1987;17:495-497. (Pubitemid 17158243)
21. McIntosh LM, Baker RE, Anderson JE. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. Biochem Cell Biol 1998;76:532-541. (Pubitemid 29102039)
22. Matsumura K, Nakano I, Fukuda N, Ikehira H, Tateno Y, Aoki Y. Proton spin-lattice relaxation time of Duchenne dystrophy skeletal muscle by magnetic resonance imaging. Muscle Nerve 1988;11:97-102. (Pubitemid 18039606)
23. Dunn JF, Zaim-Wadghiri Y. Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 1999;22:1367-1371. (Pubitemid 29468420)
24. Amthor H, Egelhof T, McKinnell I, Ladd ME, Janssen I, Weber J, et al. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul Disord 2004;14:791-796. (Pubitemid 39572399)
25. Straub V, Donahue KM, Allamand V, Davisson RL, Kim YR, Campbell KP. Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn Reson Med 2000;44:655-659. (Pubitemid 30769669)
26. Walter G, Cordier L, Bloy D, Sweeney HL. Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 2005;54:1369-1376. (Pubitemid 41740766)
27. Burstein D, Taratuta E, Manning WJ. Factors in myocardial "perfusion" imaging with ultrafast MRI and Gd-DTPA administration. Magn Reson Med 1991;20:299-305.
28. Baxter AB, Lazarus SC, Brasch RC. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. Invest Radiol 1993;28:308-312.
29. Nomura M, Takeshita G, Katada K, Nakamura M, Kizukuri T, Ogura Y, et al. A case of anaphylactic shock following the administration of Gd-DTPA [in Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 1993;53:1387-1391.
30. Krinsky G, Rofsky NM, Weinreb JC. Nonspecificity of short time inversion recovery (STIR) as a technique of fat suppression: pitfalls in image interpretation. AJR Am J Roentgenol 1996;166:523-526. (Pubitemid 26065153)
31. Scarabino T, Giannatempo GM, Popolizio T, Scarale MG, Cammisa M, Salvolini U. Fast spin echo imaging of vertebral metastasis: comparison of fat suppression techniques (FSECHESS, STIR-FSE) [in Italian]. Radiol Med (Torino) 1996; 92:180-185.
32. Drevelegas A, Pilavaki M, Chourmouzi D. Lipomatous tumors of soft tissue: MR appearance with histological correlation. Eur J Radiol 2004;50:257-267. (Pubitemid 38625728)
33. Galant J, Marti-Bonmati L, Saez F, Soler R, Alcala-Santaella R, Navarro M. The value of fat-suppressed T2 or STIR sequences in distinguishing lipoma from well-differentiated liposarcoma. Eur Radiol 2003;13:337-343. (Pubitemid 36798612)
34. Morimoto Y, Tanaka T, Masumi S, Tominaga K, Shibuya T, Kito S, et al. Significance of frequency-selective fat saturation T2- weighted MR images for the detection of bone marrow edema in the mandibular condyle. Cranio 2004;22:115-123. (Pubitemid 38597337)
35. Cook LL, Foster PJ, Karlik SJ. Pathology-guided MR analysis of acute and chronic experimental allergic encephalomyelitis spinal cord lesions at 1.5T. J Magn Reson Imaging 2005; 22:180-188.
36. Bonny JM, Zanca M, Boespflug-Tanguy O, Dedieu V, Joandel S, Renou JP. Characterization in vivo of muscle fiber types by magnetic resonance imaging. Magn Reson Imaging 1998;16:167-173. (Pubitemid 28096185)
37. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997;139:375-385. (Pubitemid 27459311)
38. Mattila KT, Lukka R, Hurme T, Komu M, Alanen A, Kalimo H. Magnetic resonance imaging and magnetization transfer in experimental myonecrosis in the rat. Magn Reson Med 1995;33:185-192.
39. Thibaud JL, Monnet A, Bertoldi D, Barthelemy I, Blot S, Carlier PG. Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging. Neuromuscul Disord 2007;17:575-584. (Pubitemid 46920965)
40. Mao J, Yan H, Brey WW, Bidgood WD Jr, Steinbach JJ, Mancuso A. Fat tissue and fat suppression. Magn Reson Imaging 1993;11:385-393.
41. Wren TA, Bluml S, Tseng-Ong L, Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008;190:W8-12.
42. Dunn JF, Tracey I, Radda GK. A 31P-NMR study of muscle exercise metabolism in mdx mice: evidence for abnormal pH regulation. J Neurol Sci 1992;113:108-113.
43. Dunn JF, Tracey I, Radda GK. Exercise metabolism in Duchenne muscular dystrophy: a biochemical and [31P]-nuclear magnetic resonance study of mdx mice. Proc Biol Sci 1993; 251:201-206.
44. Le Rumeur E, Le Tallec N, Lewa CJ, Ravalec X, de Certaines JD. In vivo evidence of abnormal mechanical and oxidative functions in the exercised muscle of dystrophic hamsters by 31P-NMR. J Neurol Sci 1995;133:16-23.
45. McCully K, Giger U, Argov Z, Valentine B, Cooper B, Chance B, et al. Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy. Muscle Nerve 1991;14:1091-1098.
46. Yuasa K, Nakamura A, Hijikata T, Takeda S. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle. BMC Musculoskel Disord 2008;9:1. (Pubitemid 351327260)
47. Hirst RC, McCullagh KJ, Davies KE. Utrophin upregulation in Duchenne muscular dystrophy. Acta Myol 2005;24: 209-216.
48. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30: 341-344. (Pubitemid 15110036)